Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. DBV and Aimmune poised to dominate peanut allergy market
  2. Comorbidities are a significant concern in people with Type 2 diabetes
  3. Vertex prepares to bolster pipeline portfolio
  4. Can Liquidia’s LIQ861 offer a more convenient and effective treprostinil option for PAH patients?
  5. Four Developers that Will Expand the Use of FLT3 Inhibitors in the AML Market

Latest Content

Vertex prepares to bolster pipeline portfolio

Pavan Kottamasu, GlobalData Healthcare & Pharmaceutical Analyst Jeffrey Leiden, M.D., Ph.D., Chairman, President, and CEO of Vertex Pharmaceuticals, took the stage on Day 1 of the 2018 J.P. Morgan (JPM) Healthcare Conference at the Westin St. Francis in San Francisco, California, US, to present Vertex Pharmaceuticals’ key achieved milestones of 2017 and proposed goals for 2018.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top